Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: health – Page 224

Research shows fatty liver disease endangers brain health

In a study examining the link between non-alcoholic fatty liver disease (NAFLD) and brain dysfunction, scientists at the Roger Williams Institute of Hepatology, affiliated to King’s College London and the University of Lausanne, found an accumulation of fat in the liver causes a decrease in oxygen to the brain and inflammation to brain tissue—both of which have been proven to lead to the onset of severe brain diseases.

The paper appears in the Journal of Hepatology.

NAFLD affects approximately 25% of the population and more than 80% of morbidly obese people. Several studies have reported the negative effects of an unhealthy diet and obesity can have on however this is believed to be the first study that clearly links NAFLD with deterioration and identifies a potential therapeutic target.

Wearable skin patch could help clinicians diagnose tumors, organ malfunction and more

Electronic wearable patches have been devised to monitor various health conditions by noninvasively detecting biomolecules on the skin surface.

A new Nature Communications study discusses the development of novel skin patches capable of deep detection of biomolecules, which correlate better and more rapidly with physiological states. For example, the photoacoustic patch described by the researchers, who are engineers at the University of California San Diego, can produce a three-dimensional (3D) map of deep tissue hemoglobin.

Already Spread to Every Continent: Unusual Fungus Has the Potential To Become a Global Health Problem

Have you ever heard of the yeast Candida auris? If not, you are most likely not the only one since it hasn’t garnered much attention. Yet. That could change.

Candida auris’s story begins in 2009 when a Japanese woman in her 70s is admitted to the Tokyo Metropolitan Geriatric Hospital. Her ear sometimes discharges something, and the doctors routinely use a cotton swab to collect samples of it. To determine what is causing the infection, they analyze the sample.

It turns out that a yeast, different from other known yeasts, is at play. We’ve all heard of baker’s yeast, a friendly microorganism used to make beer and bread. Candida auris and other Candida yeast species are extremely different; they cause serious and persistent infections that are difficult to treat with known antibiotics.

Scientists Discover a New Daily Rhythm Providing Insight Into How Brain Activity Is Fine-Tuned

Researchers discovered a new daily rhythm in a kind of synapse that dampens brain activity using a mouse model. These neural connections, known as inhibitory synapses, are rebalanced as we sleep to allow us to consolidate new information into lasting memories. The results, which were published in the journal PLOS Biology, may help explain how subtle synaptic changes improve memory in humans. Researchers from the National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health, led the study.

“Inhibition is important for every aspect of brain function. But for over two decades, most sleep studies have focused on understanding excitatory synapses,” said Dr. Wei Lu, senior investigator at NINDS. “This is a timely study to try to understand how sleep and wakefulness regulate the plasticity of inhibitory synapses.”

Kunwei Wu, Ph.D., a postdoctoral fellow in Dr. Lu’s lab, investigated what occurs at inhibitory synapses in mice during sleep and wakefulness. Electrical recordings from neurons in the hippocampus, a brain region involved in memory formation, revealed a previously unknown pattern of activity. During wakefulness, steady “tonic” inhibitory activity increased but fast “phasic” inhibition decreased. They also discovered a far larger activity-dependent enhancement of inhibitory electrical responses in awake mouse neurons, suggesting that wakefulness, rather than sleep, might strengthen these synapses to a greater extent.

Scientists use machine learning to get an unprecedented view of small molecules

A new machine learning model will help scientists identify small molecules, with applications in medicine, drug discovery and environmental chemistry. Developed by researchers at Aalto University and the University of Luxembourg, the model was trained with data from dozens of laboratories to become one of the most accurate tools for identifying small molecules.

Thousands of different small molecules, known as , transport energy and transmit cellular information throughout the human body. Because they are so small, metabolites are difficult to distinguish from each other in a blood sample analysis—but identifying these molecules is important to understand how exercise, nutrition, and metabolic disorders affect well-being.

Metabolites are normally identified by analyzing their mass and retention time with a separation technique called liquid chromatography followed by mass spectrometry. This technique first separates metabolites by running the sample through a column, which results in different flow rates—or retention times—through the measurement device.

How a common cold develops

Winter and rainy season is worst for those who have low immunity. Antibiotics have many side effects. But there high fever due to viral infection is also risky.

A cold is an infection caused by a virus. It’s a common and usually mild illness that affects the nose and throat. Find out more here: http://bit.ly/KV8y1c.

The content is intended for general information only and does not replace the need for personal advice from a qualified health professional.

FDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer

MONDAY, Dec. 19, 2022 (HealthDay News) — Patients with a high-risk bladder cancer now have a new option to treat it.

The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who have what’s called high-risk non-muscle-invasive bladder cancer (NMIBC) that hasn’t responded to the standard treatment, Bacillus Calmette-Guérin (BCG), but hasn’t spread. BCG is a vaccine typically used for tuberculosis.

“This approval provides health care professionals with an innovative treatment option for patients with high-risk NMIBC that is unresponsive to BCG therapy,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in an agency news release. “Today’s action addresses an area of critical need. The FDA remains committed to facilitating the development and approval of safe and effective cancer treatments.”

/* */